Browsing by Author Karagiannis, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 24  next >
TitleAuthor(s)Issue date
Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and womenAthyros, V. G.; Ganotakis, E.; Kolovou, G. D.; Nicolaou, V.; Achimastos, A.; Bilianou, E.; Alexandrides, T.; Karagiannis, A.; Paletas, K.; Liberopoulos, E. N.; Tziomalos, K.; Petridis, D.; Kakafika, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT studyAthyros, V. G.; Karagiannis, A.; Ganotakis, E. S.; Paletas, K.; Nicolaou, V.; Bacharoudis, G.; Tziomalos, K.; Alexandrides, T.; Liberopoulos, E. N.; Mikhailidis, D. P.24-Nov-2015
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohortAthyros, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Papageorgiou, A. A.; Ganotakis, E. S.; Tziomalos, K.; Kakafika, A. I.; Karagiannis, A.; Lambropoulos, S.; Elisaf, M. S.24-Nov-2015
Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysisChimonas, T.; Karagiannis, A.; Athyros, V. G.; Achimastos, A.; Elisaf, M. S.; Panagiotakos, D. B.24-Nov-2015
Changes of plasma noradrenaline levels in the renal and systemic circulation after successful percutaneous transluminal angioplasty in renovascular hypertensionZamboulis, C.; Karagiannis, A.; Douma, S.; Vogiatzis, K.; Doumas, M.; Byzantiades, A.; Metaxas, P.; Efremidis, S.24-Nov-2015
Dyslipidaemia, hypercoagulability and the metabolic syndromeKakafika, A. I.; Liberopoulos, E. N.; Karagiannis, A.; Athyros, V. G.; Mikhailidis, D. P.24-Nov-2015
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised studyAthyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S.24-Nov-2015
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsAthyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015
In vitro spermatogenesis as a method to bypass pre-meiotic or post-meiotic barriers blocking the spermatogenetic process: genetic and epigenetic implications in assisted reproductive technologyGeorgiou, I.; Pardalidis, N.; Giannakis, D.; Saito, M.; Watanabe, T.; Tsounapi, P.; Loutradis, D.; Kanakas, N.; Karagiannis, A.; Baltogiannis, D.; Giotitsas, N.; Miyagawa, I.; Sofikitis, N.24-Nov-2015
An integrated methodology to select the optimum site of an airport on an island using limited meteorological informationKassomenos, P. A.; Panagopoulos, I. K.; Karagiannis, A.24-Nov-2015
Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?Daskalopoulos, G. N.; Karkanaki, A.; Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.24-Nov-2015
Life Expectancy Education and theenvironment: dynamics and policy implicationsBassetti, T.; Benos, N.; Karagiannis, A.24-Nov-2015
Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT AnalysisAthyros, V. G.; Elisaf, M. S.; Alexandrides, T.; Achimastos, A.; Ganotakis, E.; Bilianou, E.; Karagiannis, A.; Liberopoulos, E. N.; Tziomalos, K.; Mikhailidis, D. P.24-Nov-2015
Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: long-term resultsKaragiannis, A.; Douma, S.; Voyiatzis, K.; Petidis, K.; Athyros, V. G.; Vizantiadis, A.; Voujiouklis, N.; Zafiriades, E.; Efremidis, S.; Zamboulis, C.24-Nov-2015
Prevalence of vascular disease in metabolic syndrome using three proposed definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Liberopoulos, E. N.; Goudevenos, I. A.; Karagiannis, A.24-Nov-2015
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S.24-Nov-2015
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015
Should atenolol still be recommended as first-line therapy for primary hypertension?Karagiannis, A.; Athyros, V. G.; Papageorgiou, A.; Tziomalos, K.; Elisaf, M. S.24-Nov-2015
Statin treatment may be beneficial to both the kidneys and the heartAthyros, V. G.; Karagiannis, A.; Liberopoulos, E. N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015